Human herpesvirus 6 and multiple sclerosis: Potential mechanisms for virus-induced disease

Herpes

Volumn 12, Issue 1, 2005, Pages 4-9

  Fotheringham, Julie ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Complement activation; Human Herpesvirus 6; Molecular mimicry; Multiple sclerosis

Indexed keywords

AUTOIMMUNITY; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOLOGY; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE INJURY; VIRUS REACTIVATION;

COMPLEMENT ACTIVATION; DNA, VIRAL; HERPESVIRUS 6, HUMAN; HUMANS; MULTIPLE SCLEROSIS; ROSEOLOVIRUS INFECTIONS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 6;

EID: 20844450186     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001;7: 115-121.
2. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R et al. Clonal expansions of CD8(+) T cells dominate the T-cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000;192: 393-404
3. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002;125: 2202-2212.
4. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004;101: 2428-2433.
5. Crawford MP, Yan SX, Ortega SB, Mehta RS, Hewitt RE, Price DA et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004;103:4222-4231.
6. Jacobsen M, Cepok S, Quak E, Happel M, Gaber R, Ziegler A et al. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002;125: 538-550.
7. Sola P, Merelli E, Marasca R, Poggi M, Luppi M, Montorsi M et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993;56:917-919.
8. Wilborn F, Schmidt CA, Brinkmann V, Jendroska K, Oettle H, Siegert W. A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994;49: 213-214.
9. Liedtke W, Malessa R, Faustmann PM, Eis-Hubinger AM. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995;1:253-258.
10. Nielsen L, Larsen AM, Munk M, Vestergaard BF. Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand Suppl 1997; 169:76-78.
11. Soldan S, Berti SR, Salem N, Secchiero P, Flamand L, Calabresi PA et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997;3:1394-1397.
12. Ablashi DV, Lapps W, Kaplan M, Whitman JE, Richert JR, Pearson GR. Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult Scler 1998;4:490-496.
13. Enbom M, Wang FZ, Fredrikson S, Martin C, Dahl H, Linde A. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 1999;6:545-549.
14. Ongradi J, Rajda C, Marodi CL, Csiszar A, Vecsei L. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J Neurovirol 1999;5:529-532.
15. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB et al, Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000;16:179-191.
16. Taus C, Pucci E, Cartechini E, Fie A, Giuliani G, Clementi M et al. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand 2000;101:224-228.
17. Xu Y, Linde A, Fredrikson S, Dahl H, Winberg G. HHV-6 A- or B-specific P41 antigens do not reveal virus variant-specific IgG or IgM responses in human serum. J Med Virol 2002;66:394-399.
18. Friedman JE, Lyons MJ, Cu G, Ablashi DV, Whitman JE, Edgar M et al. The association of the human herpesvirus-6 and MS. Mult Scler 1999;5:355-362.
19. Enbom M, Linde A, Evengard B. No evidence of active infection with human herpesvirus 6 (HHV-6) or HHV-8 in chronic fatigue syndrome. J Clin Microbiol 2000;38:2457.
20. Martin C, Enbom M, Soderstrom M, Fredrikson S, Dahl H, Lycke J et al. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997;95: 280-283.
21. Fillet A, Lozeron MP, Agut H, Lyon-Caen O, Liblau R. HHV-6 and multiple sclerosis. Nat Med 1998;4: 537; author reply 538.
22. Goldberg SH, Albright AV, Lisak RP, Gonzalez-Scarano F. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol 1999;5:134-139.
23. Mirandola PA, Stefan E, Brambilla G, Campadelli-Fiume, Grimaldi LM. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 1999;53: 1367-1368.
24. Tejada-Simon, Zang MV, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol 2002;76: 6147-6154.
25. Al-Shammari S, Nelson SR, Voevodin A. HHV-6 DNAaemia in patients with multiple sclerosis in Kuwait. Acta Neurol Scand 2003;107: 122-124.
26. Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003;53:189-197.
27. Torelli G, Barozzi P, Marasca R, Cocconcelli P, Merelli E, Ceccherini-Nelli L et al. Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J Med Virol 1995;46:178-188.
28. Merelli E, Bedin R, Sola P, Barozzi P, Mancardi GL, Ficarra G et al. Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children. J Neurol 1997;244:450-454.
29. Mayne M, Krishnan J, Metz L, Nath A, Auty A, Sahai BM et al. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann Neurol 1998;44: 391-394.
30. Rotola A, Cassai E, Tola M, Granieri RE, Di Luca D. Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;67:529-531.
31. Hay KA, Tenser RB. Leukotropic herpesviruses in multiple sclerosis. Mult Scler 2000;6:66-68.
32. Kim JS, Lee KS, Park JH, Kim MY, Shin WS. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. Eur Neurol 2000;43:170-173.
33. Rotola A, Caselli E, Cassai E, Tola MR, Granieri E, Luca DD. Novel human herpesviruses and multiple sclerosis. J Neurovirol 2000 (Suppl 6):S88-S91.
34. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 2003;69:111-117.
35. Cirone M, Cuomo L, Zompetta C, Ruggieri S, Frati L, Faggioni A et al. Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens. J Med Virol 2002; 68:268-272.
36. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995;92: 7440-7444.
37. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 1996;2:249-258.
38. Coates AR, Bell J. HHV-6 and multiple sclerosis. Nat Med 1998;4:537-538.
39. Cermelli C, Berti R, Soldan SS, Mayne M, D'Ambrosia JM, Ludwin SK et al. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 2003;187:1377-1387.
40. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234: 596-601.
41. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, Gonzalez-Scarano F. The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol 1998;4:486-494.
42. He J, McCarthy M, Zhou Y, Chandran B, Wood C. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1991;70: 1296-1300.
43. Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci U S A 1996;88: 5922-5926.
44. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 1999;73:8040-8052.
45. Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y et al. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 1999;73:8053-8063.
46. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;i:1065-1067.
47. Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 2003;61: 1405-1411.
48. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000;47:306-313.
49. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 2003;187:1365-1376.
50. Jacobson S. Association of human herpesvirus-6 and multiple sclerosis: here we go again? J Neurovirol 1998;4:471-473.
51. Tyler KL. Human herpesvirus 6 and multiple sclerosis: the continuing conundrum. J Infect Dis 2003;187:1360-1364.
52. Alvarez-Lafuente R, De las Heras V, Bartolome M, Picazo JJ, Arroyo R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol 200461:1523-1527.
53. Opsahl ML, Kennedy PG. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005;128:516-527.
54. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999;99: 817-827.
55. Greenstone HL, Santoro F, Lusso P, Berger EA. Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function. J Biol Chem 2002;277:39112-39118.
56. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 2004;78: 4385-4388.
57. Mori Y, Akkapaiboon P, Yonemoto S, Koike M, Takemoto M, Sadaoka T et al. Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol 2004;78:4609-4616.
58. Mori Y, Yang X, Akkapaiboon P, Okuno T, Yamanishi K. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 2003;77: 4992-4999.
59. Santoro F, Greenstone HL, Insinga A, Liszewski MK, Atkinson JP, Lusso P et al. Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J Biol Chem 2003;278: 25964-25969.
60. Marie JC, Astier AL, Rivailler P, Rabpurdin-Combe C, Wild TF, Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 2002;3: 659-666.
61. Vandevyver C, Mertens N, van den Elsen P, Medaer R, Raus J, Zhang J. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995;25:958-968.
62. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994;152: 5581-5592.
63. Zang YC, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerpsis. J Immunol 2004; 172:5120-5127.
64. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179:973-984
65. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990;247:718-721.
66. Naucler CS, Larsson S, Moller E. A novel mechanism for virus-induced autoimmunity in humans. Immunol Rev 1996;152:175-192.
67. Soderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Moller E. Cytomegalovirus-induced CD13-specific autoimmunity-a possible cause of chronic graft-vs-host disease. Transplantation 1996;61:600-609.
68. Soderberg C, Sumitran-Karuppan S, Ljungman P, Moller E. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. Transplantation 1996;61:594-600.
69. Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L et al. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 2001;50:486-493.
70. Fogdell-Hahn A, Soldan SS, Shue S, Akhyani N, Refai H, Ahlquist J et al. Co-purification of soluble membrane cofactor protein (MCP; CD46) and human herpesvirus type 6 variant a genome in serum from multiple sclerosis patients. Virus Res 2005;110:57-63.
71. Pinter C, Beltrami S, Caputo D, Ferrante P, Clivio A. Presence of autoantibodies against complement regulatory proteins in relapsing-remitting multiple sclerosis. J Neurovirol 2000; 6(Suppl 2): S42-S46.
72. Marschang P, Sodroski J, Wurzner R, Dierich MP. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur J Immunol 1995;25:285-290.
73. Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 1994;205:82-92.
74. Spear GT, Lurain NS, Parker CJ, Ghassemi M, Payne GH, Saifuddin M. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J Immunol 1995;155: 4376-4381.
75. Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002;3:705-714.
76. Dietrich J, Blumberg BM, Roshal M, Baker JV, Hurley SD, Mayer-Proschel M. Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J Neurosci 2004; 24:4875-4883.